Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-κB activation

AIDS

Volumn 10, Issue 5, 1996, Pages 469-475

  Navarro, Joaquín ^a   Punzón, M Carmen ^b   Pizarro, Angel ^c   Fernández Cruz, Eduardo ^a   Fresno, Manuel ^b   Muñoz Fernández, M Angeles ^a,b,d  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b CSIC   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

HIV infection; Interferon ; Interleukin 10; Nuclear factor B; Pentoxifylline; T helper (Th) 1; Th2; Tumour necrosis factor

Indexed keywords

ANTIGEN P24; ANTITHROMBOCYTIC AGENT; CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; MONOCLONAL ANTIBODY CD3; PENTOXIFYLLINE; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL PROLIFERATION; CYTOFLUOROMETRY; ELECTROPHORETIC MOBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0029970261     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199605000-00004     Document Type: Article

References (32)

1. Fauci AS: Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 1993, 262:1011-1018.
2. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993, 57:183-289.
3. 2, IL-1β and TNFα by peripheral blood monocytes from HIV-positive individuals at early stages of HIV infection. J Acquir Immune Defic Syndr 1993, 6:1017-1023.
4. Rosenberg ZF, Fauci AS: Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today 1990, 11:176-180.
5. Clerici M, Shearer GM: The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994, 15:575-581.
6. Barcellini W, Rizzardi CP, Borghi MO, Fain C, Lazzarin A, Meroni PL: TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994, 8:757-762.
7. Aukrust P, Liabakk NB, Muller F, Lien E, Espevik T, Froland SS: Serum levels of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in human immunodeficiency virus type 1 infection. Correlation to clinical, immunological and virological parameters. J Infect Dis 1994, 169:420-424.
8. Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB: Tumor necrosis factor a activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc Natl Acad Sci USA 1989, 86:5974-5978.
9. Osborn L, Kunkel S, Nabel CJ: Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc Natl Acad Sci USA 1989, 86:2336-2340.
10. Clerici M, Wynn T, Berzofzsky JA, et al. : Role of interleukin 10 in helper T cell disfunction in asymptomatic individuals infected with human immunodeficiency virus. J Clin Invest 1994, 93:768-775.
11. Moore KW, O'Carra A, de Waal Malefyt R, Vieira P, Mossmann TR: Interleukin 10. Ann Rev Immunol 1993, 11:165-190.
12. Spits H, de Vries JE: Interleukin 10. Curr Opin Immunol 1992, 4:314-320.
13. Samlaska CP, Winfield EA: Pentoxifylline. J Am Acad Dermatol 1994, 30:603-621.
14. Tilg H, Eibl B, Pichl M, et al: Immune response modulation by pentoxifylline in vitro. Transplantation 1993, 56:196-201.
15. Sullivan GW, Carper AT, Novick WJ, Mandell GL: Inhibition of the inflamatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun 1988, 56:1772-1729.
16. Strieter RM, Remick DG, Ward PA et al.: Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun 1988, 155:1230-1236.
17. Han J, Thompson P, Beutler B: Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990, 172:391-394.
18. Zabel P, Scahde FV, Schallak M: Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 1993, 187:447-463.
19. Zabel P, Schonharting MM, Wolter DT, Schade UF: Oxpentoxifylline in endotoxaemia. Lancet 1989, 2:1474-1477.
20. Dezube BJ, Sherman ML, Fridovich-Keil JL, Allen-Ryan J, Pardee AB: Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: a pilot study. Cancer Immunol Immunother 1993, 36:57-60.
21. Gramnger W, Thalhammer F, Lockr G: Pentoxifylline in cerebral malaria. J Infect Dis 1991, 164:829.
22. Fazely F, Dezube BJ, Allen-Ryan J, Pardee AB, Ruprecht RM: Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells. Blood 1991, 77:1653-1656.
23. Dezube BJ, Pardee AB, Chapman B, et al.: Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. J Acquir Immune Defic Syndr 1993, 6:787-794.
24. Luke DR, McCreedy BJ, Sarnoski TP, et al.: Phase I/II study of pentoxifyllyne with zidovudine on HIV-1 growth in AIDS patients. Int J Clin Pharm Ther Tox 1993, 31:343-350.
25. Dezube BJ: Pentoxifylline for the treatment of infection with human immunodeficiency virus. Clin Infect Dis 1994, 18:285-287.
26. Dezube BJ, Lederman MM, Spritzler JG, et al.: High-dose pentoxyfylline in patients with AIDS: inhibition of tumor necrosis factor production. J Infect Dis 1995, 171:1628-1632.
27. Biswas DK, Dezuke BJ, Ahlers CM, Pardee AB: Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-κB action. J Acquir Immune Defic Syndr 1993, 6:778-786.
28. Pimentel-Muiños FX, Muñoz-Fernandez MA, Fresno M: Control of T lymphocyte activation and interleukin 2 receptor expression by endogenously secreted lymphokines. J Immunol 1994, 152:5714-5722.
29. Rosenthal LA, Taub DD, Moors MA, et al.: Methylxanthine-induced inhibition of antigen- and superantigen-specific activation of T and B lymphocytes. Immunopharmacology 1992, 24:203-217.
30. Chen D, Rothenberg EV: Interleukin-2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J Exp Med 1994; 179:931-942.
31. DeWall Malefyt R, Yssel H, DeVries JA: Direct effects of IL-10 on subsets of human CD4+ T-cell clones and resting T cells. J Immunol 1993, 150:4754-4765.
32. Maggi E, Mazzetti M, Ravina A, Annunziato F, et al.: Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science 1994, 265:244-248.